Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2017-03-21 | 2017-03-21 |
| Drug Identification Number | 02186845 | 02186845 |
| Brand name | TRASYLOL | TRASYLOL |
| Common or Proper name | APROTININ (BOVINE) | APROTININ (BOVINE) |
| Company Name | NORDIC GROUP B.V. | NORDIC GROUP B.V. |
| Ingredients | APROTININ | APROTININ |
| Strength(s) | 10000UNIT | 10000UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 50 ML VIAL (500,000 KIU); 200 ML VIAL (2,000,000 KIU) | 50 ML VIAL (500,000 KIU); 200 ML VIAL (2,000,000 KIU) |
| ATC code | B02AB | B02AB |
| ATC description | ANTIFIBRINOLYTICS | ANTIFIBRINOLYTICS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2014-10-30 | 2014-10-30 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Canadian responsibility for Trasylol (aprotinin) now resides with Nordic Group B.V. (represented in Canada by Methapharm Inc.). For all inquiries, please contact Methapharm Medical Affairs at medinfo@methapharm.com, phone: 1-800-287-7686 ext 7804, or by fax: (519) 751-9149 | Canadian responsibility for Trasylol (aprotinin) now resides with Nordic Group B.V. (represented in Canada by Methapharm Inc.). For all inquiries, please contact Methapharm Medical Affairs at medinfo@methapharm.com, phone: 1-800-287-7686 ext 7804, or by fax: (519) 751-9149 |
| Health Canada comments |